Skip to content
OpenCapital
Get started

Rapid Micro Biosystems RPID Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price

Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price at other companies

Ginkgo Bioworks logo
Ginkgo BioworksDNA
——
Lifecore Biomedical, Inc. logo
Lifecore Biomedical, Inc.LFCR
——
Simulations Plus logo
Simulations PlusSLP
——

Other financials

Income statement

See full
Revenue$8.0M+11.1%
Gross profit$371.0K-8.2%
Operating income-$13.9M-18.8%
Net income-$14.3M-26.7%
EPS (diluted)-$0.31-19.2%

Balance sheet

See full
Cash & equivalents$14.1M-26.8%
Total debt$23.8M+301%
Total equity$20.4M-68.9%
Total assets$62.4M-27.0%

Cash flow

See full
Operating cash flow-$15.1M-66.1%
CapEx$394.0K+23.5%
Free cash flow-$15.5M-64.7%

Valuation

See full
Market cap$86.19M-43.8%
Enterprise value$95.86M-31.7%
P/S2.5×-2.6×

Profitability

See full
Operating margin-144.2%-12.7pp
Net margin-145.8%-5.0pp
FCF margin-110.5%-14.9pp

Returns & leverage

See full
Return on equity-116.7%-620pp
Debt / equity1.2×+1.1×
Current ratio2.6×-2.0×

Where this comes from

Reported directly by Rapid Micro Biosystems in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice.

The official record: Rapid Micro Biosystems’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rapid Micro Biosystems's share-based compensation arrangement by share-based payment award, options, outstanding, weighted average exercise price.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Rapid Micro Biosystems's share-based compensation arrangement by share-based payment award, options, outstanding, weighted average exercise price?
Rapid Micro Biosystems (RPID) reported share-based compensation arrangement by share-based payment award, options, outstanding, weighted average exercise price of $2.74 in Q1 2026.
How has Rapid Micro Biosystems's share-based compensation arrangement by share-based payment award, options, outstanding, weighted average exercise price changed year-over-year?
Rapid Micro Biosystems's share-based compensation arrangement by share-based payment award, options, outstanding, weighted average exercise price increased by 7.9% year-over-year, from $2.54 to $2.74.
What is the long-term trend for Rapid Micro Biosystems's share-based compensation arrangement by share-based payment award, options, outstanding, weighted average exercise price?
Over 4 years (2021 to 2025), Rapid Micro Biosystems's share-based compensation arrangement by share-based payment award, options, outstanding, weighted average exercise price has grown at a -16.8% compound annual growth rate (CAGR), from $5.06 to $2.43.